Matthias Bureik

2.3k total citations
93 papers, 1.8k citations indexed

About

Matthias Bureik is a scholar working on Pharmacology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthias Bureik has authored 93 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 51 papers in Molecular Biology and 28 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthias Bureik's work include Pharmacogenetics and Drug Metabolism (61 papers), Hormonal Regulation and Hypertension (21 papers) and Microbial Metabolic Engineering and Bioproduction (19 papers). Matthias Bureik is often cited by papers focused on Pharmacogenetics and Drug Metabolism (61 papers), Hormonal Regulation and Hypertension (21 papers) and Microbial Metabolic Engineering and Bioproduction (19 papers). Matthias Bureik collaborates with scholars based in Germany, China and United States. Matthias Bureik's co-authors include Rita Bernhardt, Călin-Aurel Drăgan, Frank T. Peters, Hans H. Maurer, Gerhard Wolber, Andy Zöllner, David Machalz, Maria Kristina Parr, Rolf W. Hartmann and Michael Lisurek and has published in prestigious journals such as Biochemistry, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Matthias Bureik

91 papers receiving 1.8k citations

Peers

Countries citing papers authored by Matthias Bureik

Since Specialization

Citations

This map shows the geographic impact of Matthias Bureik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Bureik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Bureik more than expected).

Fields of papers citing papers by Matthias Bureik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Bureik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Bureik. The network helps show where Matthias Bureik may publish in the future.

Co-authorship network of co-authors of Matthias Bureik

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Bureik. A scholar is included among the top collaborators of Matthias Bureik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Bureik. Matthias Bureik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced and rearranged metabolite structures after metandienone administration: New promising metabolites for potential long-term detection 2025 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), Francesco Molaioni, Nils E. Schlörer, Xavier de la Torre, Matthias Bureik, Francesco Botrè, Maria Kristina Parr	1
2	Efficient sex hormone biosensors in Saccharomyces cerevisiae cells to evaluate human aromatase activity and inhibition 2025 ·Scientific Reports ·(unknown), Matthias Bureik, Mario Andrea Marchisio	1
3	Integrated Virtual Screening Approach Identifies New CYP19A1 Inhibitors 2025 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), Ya Chen, (unknown), Matthias Bureik, Johannes Kirchmair, Mario Andrea Marchisio, Gerhard Wolber	1
4	Development of an efficient insecticide substrate and inhibitor screening system of insect P450s using fission yeast 2023 ·Insect Biochemistry and Molecular Biology ·Xiang Li, Lianyun Lin, Zhi Li, Hadiatullah Hadiatullah, (unknown), (unknown), Xin Yang, Wei Chen, Shijun You, Matthias Bureik, Zhiguang Yuchi	2
5	Monitoring of autoantibodies against CYP4Z1 in patients with colon, ovarian, or prostate cancer 2022 ·Immunobiology ·Christopher Khayeka‐Wandabwa, (unknown), Yingjie Jia, Matthias Bureik	5
6	Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase 2021 ·Frontiers in Endocrinology ·(unknown), (unknown), David Machalz, Francesco Botrè, Gerhard Wolber, Matthias Bureik, Maria Kristina Parr	2
7	Futile cycling by human microsomal cytochrome P450 enzymes within intact fission yeast cells 2021 ·Archives of Biochemistry and Biophysics ·(unknown), Kun Zhou, (unknown), (unknown), Mario Andrea Marchisio, Matthias Bureik	1
8	New luciferin-based probe substrates for human CYP26A1 2020 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), Xue Zhang, (unknown), Erik J. Sorensen, Matthias Bureik	6
9	Comparison of cytochrome P450 expression in four different human osteoblast models 2017 ·Biological Chemistry ·(unknown), Janak L. Pathak, Yongqiang Zhu, Matthias Bureik	9
10	Overcoming the metabolic burden of protein secretion in Schizosaccharomyces pombe – A quantitative approach using 13C-based metabolic flux analysis 2013 ·Metabolic Engineering ·Tobias Klein, (unknown), (unknown), Matthias Bureik, (unknown), Elmar Heinzle, Konstantin Schneider	32
11	Coexpression of CPR from Various Origins Enhances Biotransformation Activity of Human CYPs in S. pombe 2013 ·Applied Biochemistry and Biotechnology ·(unknown), (unknown), Frank T. Peters, Hans H. Maurer, Alain Hehn, Frédéric Bourgaud, Matthias Bureik	21
12	Production of Ibuprofen Acyl Glucosides by Human UGT2B7 2011 ·Drug Metabolism and Disposition ·(unknown), Călin-Aurel Drăgan, (unknown), Matthias Bureik	27
13	CYP21-catalyzed production of the long-term urinary metandienone metabolite 17β-hydroxymethyl-17α-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping 2009 ·Biological Chemistry ·Andy Zöllner, Maria Kristina Parr, Călin-Aurel Drăgan, (unknown), Nils E. Schlörer, Frank T. Peters, Hans H. Maurer, Wilhelm Schänzer, Matthias Bureik	32
14	Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine 2009 ·Forensic Science International ·Frank T. Peters, (unknown), Andrea E. Schwaninger, Christoph Sauer, Josef Zapp, Matthias Bureik, Hans H. Maurer	18
15	Increased TCA cycle activity and reduced oxygen consumption during cytochrome P450‐dependent biotransformation in fission yeast 2006 ·Yeast ·(unknown), Lars M. Blank, Matthias Bureik	24
16	Vitamin D3 Metabolism in Human Glioblastoma Multiforme: Functionality of CYP27B1 Splice Variants, Metabolism of Calcidiol, and Effect of Calcitriol 2005 ·Clinical Cancer Research ·Britta Diesel, (unknown), Matthias Bureik, Rita Bernhardt, Markus Seifert, Jörg Reichrath, Ulrike Fischer, Eckart Meese	70
17	Inhibition of aldosterone biosynthesis by staurosporine 2005 ·Biological Chemistry ·Matthias Bureik, (unknown), Christopher J. Kenyon, Rita Bernhardt	2
18	A fluorimetric assay for cortisol 2005 ·Analytical and Bioanalytical Chemistry ·Daniel Appel, Rolf D. Schmid, Călin-Aurel Drăgan, Matthias Bureik, Vlada B. Urlacher	46
19	The adrenodoxin-like ferredoxin of Schizosaccharomyces pombe mitochondria 2004 ·Journal of Inorganic Biochemistry ·Burkhard Schiffler, Matthias Bureik, Wolfgang Reinle, Eva‐Christina Müller, Frank Hannemann, Rita Bernhardt	36
20	Efficient conversion of 11-deoxycortisol to cortisol (hydrocortisone) by recombinant fission yeast 2004 ·FEMS Yeast Research ·(unknown), (unknown), Frank Hannemann, Rita Bernhardt, Matthias Bureik	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact